lilly retatrutide Eli Preparing Applications After Positive Weight-Loss Data Lilly, with new data, to

Jan 20, 2026 9 min read IN THIS ARTICLE KEY TAKEAWAYS GLP-1 medications can reduce appetite and temporarily lower energy

The average weight loss per month on GLP-1 medications improves significantly with consistent physical activity

I created social media content for many competitors at the Worlds Strongest Man and the Arnold Classic, so I was around that world

SSRIs are recommended as first-line pharmacological treatment for depression and generalised anxiety disorder (GAD) in adults, in line with NICE guidelines (NG222 and CG113)

The majority of other cognitive domains were unaffected at baseline (Table 2)

Lipid Panel Changes Retatrutide consistently improves lipid profiles: Triglycerides: Significant reductions, driven by reduced hepatic VLDL production and improved fat metabolism LDL cholesterol: Modest reductions observed HDL cholesterol: Tends to be preserved or mildly increased Non-HDL cholesterol: Meaningful improvements across studies These lipid changes are clinically relevant and contribute to the overall cardiovascular risk reduction profile